Jamison Private Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jamison Private Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$213K	Buy	407 +2	+0.5%	+$1.02K	0.02%	221
2026 Q2	$201K	Buy	+405	New	+$179K	0.02%	222
2024 Q4	–	Sell	-5	Closed	-$2.33K	–	474
2024 Q3	$2.33K	Hold	5	–	–	﹤0.01%	419
2024 Q2	$2.34K	Hold	5	–	–	﹤0.01%	384
2024 Q1	$2.09K	Buy	+5	New	+$2.11K	﹤0.01%	396

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Jamison Private Wealth Management's VRTX Position: Q3 2026 in Review

Jamison Private Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.49% in Q3 2026, buying an estimated $1.02K and bringing the position to 407 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #221.

Jamison Private Wealth Management first reported a position in VRTX in Q1 2024 and has held it in 5 quarters since. 884 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Jamison Private Wealth Management held 407 shares of Vertex Pharmaceuticals worth $213K as of Q3 2026.
Jamison Private Wealth Management bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
Vertex Pharmaceuticals made up 0.02% of Jamison Private Wealth Management's portfolio in Q3 2026, its #221 holding.
Jamison Private Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
884 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Jamison Private Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.